तुलना करने के लिए मीट्रिक्स | BVXP | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBVXPपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | 12.8x | −4.7x | −0.3x | |
PEG अनुपात | −2.50 | −0.01 | 0.00 | |
क़ीमत/बुक | 8.6x | 2.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 7.6x | 5.1x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | 113.7% | 107.1% | 61.2% | |
उचित मूल्य अपसाइड | अनलॉक करें | 0.0% | 7.2% | अनलॉक करें |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.